Drug intelligence / Profile preview

mupirocin + benzoyl peroxide

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Topical
01

Overview

**Mupirocin + benzoyl peroxide** is a topical combination formulation consisting of the antibiotic mupirocin and the antibacterial/keratolytic agent benzoyl peroxide. Mupirocin is a topical antibiotic that works by inhibiting bacterial protein synthesis through reversible binding to bacterial isoleucyl-tRNA synthetase, effectively treating infections caused by susceptible strains of *Staphylococcus aureus* and *Streptococcus pyogenes*, and is widely used in impetigo and other skin infections[10][2][14][12][8]. Benzoyl peroxide acts primarily as an oxidizer that denatures bacterial cell membranes, most notably effective against *Cutibacterium acnes* in acne, as well as having mild keratolytic and anti-inflammatory properties. Benzoyl peroxide is notable for the fact that bacteria do not develop resistance to it[10][9][15].\nThe combination of mupirocin and benzoyl peroxide is designed to harness synergistic antibacterial mechanisms (antibiotic and oxidizing action) and is sometimes considered for complicated skin infections, folliculitis, and acne with secondary infection, although it is not a first-line standard, and clinical data on efficacy are limited[7][11]. This combination is occasionally used in compounded preparations for topical application, but is not available as a widely-approved fixed-dose commercial product.

Other names
mupirocin + benzoyl peroxide
02

Targets

IleRS (Isoleucyl-tRNA synthetase)

Beyond the preview

Go deeper on mupirocin + benzoyl peroxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mupirocin + benzoyl peroxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call